A detailed history of Valley National Advisers Inc transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Valley National Advisers Inc holds 1,000 shares of INMB stock, worth $4,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$4,420
Previous $8,000 37.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 02, 2021

BUY
$9.29 - $19.33 $9,290 - $19,330
1,000 New
1,000 $18,000
Q1 2021

May 07, 2021

SELL
$11.61 - $26.85 $23,220 - $53,700
-2,000 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$7.51 - $17.22 $15,020 - $34,440
2,000 New
2,000 $34,000

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $79.3M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.